Human p27 KIP 1 (CDKN1B) activation kit by CRISPRa

CAT#: GA100739

CDKN1B CRISPRa kit - CRISPR gene activation of human cyclin dependent kinase inhibitor 1B



  See Other Versions

CNY 12255.00


货期*
4周

规格
    • 1 kit

Product images

推荐一起购买 (3)
CDKN1B/p27KIP1 Rabbit polyclonal Antibody
    • 100 ul

CNY 1999.00
CNY 3280.00

热销推荐


CDKN1B (Myc-DDK-tagged)-Human cyclin-dependent kinase inhibitor 1B (p27, Kip1) (CDKN1B)
    • 10 ug

CNY 3600.00
CNY 3705.00


p27 Kip 1 Rabbit monoclonal Antibody
    • 100 ul

CNY 1999.00
CNY 3280.00

热销推荐

Specifications

Product Data
Format 3 gRNAs (5ug each), 1 scramble ctrl (10ug) and 1 enhancer vector (10ug)
Symbol CDKN1B
Locus ID 1027
Kit Components

GA100739G1, p27 KIP 1 gRNA vector 1 in pCas-Guide-GFP-CRISPRa

GA100739G2, p27 KIP 1 gRNA vector 2 in pCas-Guide-GFP-CRISPRa

GA100739G3, p27 KIP 1 gRNA vector 3 in pCas-Guide-GFP-CRISPRa

1 CRISPRa-Enhancer vector, SKU GE100056

1 CRISPRa scramble vector, SKU GE100077

Reference Data
RefSeq NM_004064
Synonyms CDKN4; KIP1; MEN1B; MEN4; P27KIP1
Summary This gene encodes a cyclin-dependent kinase inhibitor, which shares a limited similarity with CDK inhibitor CDKN1A/p21. The encoded protein binds to and prevents the activation of cyclin E-CDK2 or cyclin D-CDK4 complexes, and thus controls the cell cycle progression at G1. The degradation of this protein, which is triggered by its CDK dependent phosphorylation and subsequent ubiquitination by SCF complexes, is required for the cellular transition from quiescence to the proliferative state. Mutations in this gene are associated with multiple endocrine neoplasia type IV (MEN4). [provided by RefSeq, Apr 2014]
*Delivery time may vary from web posted schedule. Occasional delays may occur due to unforeseen complexities in the preparation of your product. International customers may expect an additional 1-2 weeks in shipping.

Documents

Other Versions

Customer Reviews 
Loading...